NDC Pharmacologic Class N0000191259 Programmed Death Receptor-1-directed Antibody Interactions [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0003-3734Opdivo NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.Human Prescription Drug
0003-3772Opdivo NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.Human Prescription Drug
0003-3774Opdivo NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.Human Prescription Drug
0006-3026Keytruda PembrolizumabInjection, SolutionIntravenousMerck Sharp & Dohme Corp.Human Prescription Drug
0006-3029Keytruda PembrolizumabInjection, Powder, Lyophilized, For SolutionIntravenousMerck Sharp & Dohme Corp.Human Prescription Drug
50242-917Tecentriq AtezolizumabInjection, SolutionIntravenousGenentech, Inc.Human Prescription Drug

There are 6 NDC products with the pharmacologic class Programmed Death Receptor-1-directed Antibody Interactions [MoA].